Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Thursday's Pre-Market Session

 

Gainers

  • Regulus Therapeutics (NASDAQ:RGLS) stock rose 7.6% to $0.22 during Thursday's pre-market session. The market value of their outstanding shares is at $32.2 million.
  • PAVmed (NASDAQ:PAVM) stock moved upwards by 7.08% to $1.36. The market value of their outstanding shares is at $119.7 million.
  • Selecta Biosciences (NASDAQ:SELB) shares rose 6.5% to $0.81. The company's market cap stands at $122.6 million.
  • First Wave BioPharma (NASDAQ:FWBI) shares moved upwards by 6.31% to $0.69. The market value of their outstanding shares is at $11.5 million.
  • AlloVir (NASDAQ:ALVR) shares increased by 6.02% to $4.75. The market value of their outstanding shares is at $310.4 million.
  • Trevena (NASDAQ:TRVN) stock moved upwards by 5.81% to $0.32. The market value of their outstanding shares is at $52.9 million.

Losers

  • Teladoc Health (NYSE:TDOC) stock fell 43.1% to $31.86 during Thursday's pre-market session. The market value of their outstanding shares is at $5.1 billion. The company's, Q1 earnings came out yesterday.
  • Sio Gene Therapies (NASDAQ:SIOX) shares fell 36.99% to $0.38. The market value of their outstanding shares is at $28.0 million.
  • Align Tech (NASDAQ:ALGN) stock declined by 22.6% to $279.0. The company's market cap stands at $21.9 billion. As per the press release, Q1 earnings came out yesterday.
  • Cosmos Holdings (NASDAQ:COSM) shares fell 21.84% to $1.11. The company's market cap stands at $19.4 million.
  • Ocuphire Pharma (NASDAQ:OCUP) shares decreased by 18.46% to $1.9. The company's market cap stands at $36.0 million.
  • Xenetic Biosciences (NASDAQ:XBIO) shares fell 15.09% to $0.72. The market value of their outstanding shares is at $9.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.